about
Impaired DNA replication within progenitor cell pools promotes leukemogenesis.Irradiation selects for p53-deficient hematopoietic progenitors.Solution characterization of the extracellular region of CD147 and its interaction with its enzyme ligand cyclophilin AKnockdown of HPRT for selection of genetically modified human hematopoietic progenitor cellsPosttransplant Hodgkin lymphoma preceded by polymorphic posttransplant lymphoproliferative disorder: report of a pediatric case and review of the literature.Relative fitness of hematopoietic progenitors influences leukemia progression.Targeting developmental pathways in children with cancer: what price success?Integrated genomic analyses identify WEE1 as a critical mediator of cell fate and a novel therapeutic target in acute myeloid leukemia.Activating PAX gene family paralogs to complement PAX5 leukemia driver mutationsInfluenza immunization practices among pediatric oncologists
P50
Q24816866-0A1F2014-D047-4BD5-8C72-31C4BAAD7E3AQ30979212-DC152E08-0FC0-4C84-8532-6A2F91DB2252Q34134286-0CC9EB79-6A84-455E-A634-5B9998451342Q34649263-19ECD4A5-4EAE-485C-9360-813C2C56D32BQ36728534-80012812-2ACE-4072-94B5-0ECF48A3769AQ36895929-EE530332-45CD-4A97-8DEB-9DFC9FF94ECEQ36905620-8DF7213E-109E-4810-993B-F31CDF11B5E3Q42149280-C431356D-7F0E-4EE9-94C9-ED37B786BE89Q58739187-126717E3-FB21-49E5-8362-5E29FA517BAFQ78901844-E3388A46-336F-4A7A-871C-ABAE9DB9AFB4
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Christopher C. Porter
@ast
Christopher C. Porter
@en
Christopher C. Porter
@es
Christopher C. Porter
@nl
Christopher C. Porter
@sl
type
label
Christopher C. Porter
@ast
Christopher C. Porter
@en
Christopher C. Porter
@es
Christopher C. Porter
@nl
Christopher C. Porter
@sl
prefLabel
Christopher C. Porter
@ast
Christopher C. Porter
@en
Christopher C. Porter
@es
Christopher C. Porter
@nl
Christopher C. Porter
@sl
P106
P1153
7202934019
P21
P31
P496
0000-0001-8774-0180